Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Mar;13(3):201-5.
doi: 10.3779/j.issn.1009-3419.2010.03.03.

[The sonodynamic effects of Chlorin e6 on the proliferation of human lung adenocarcinoma cell SPCA-1]

[Article in Chinese]
Affiliations

[The sonodynamic effects of Chlorin e6 on the proliferation of human lung adenocarcinoma cell SPCA-1]

[Article in Chinese]
Ruinian Zheng et al. Zhongguo Fei Ai Za Zhi. 2010 Mar.

Abstract

Background and objective: Sonodynamic therapy (SDT) is a promising new approach for cancer therapy. The purpose of this study is to detect the effects of SDT on the cell proliferation of human lung adenocarcinoma cell SPCA-1, using Chlorin e6 as a sonosensitizing agent activated by ultrasound.

Methods: SPCA-1 and normal peripheral mononuclear cell (PMNC) were treated with ultrasound or Chlorin e6 alone and combined. Cell proliferation was determined by MTT assay, and cell morphology was studied by inverted microscope after 6 h treated.

Results: 1.0 MHz ultrasound (1.0 W/ cm(2)-2.0 W/cm2 x 60 s) and Chlorin e6 (0.4 mg/mL-3.2 mg/mL) inhibited the cell proliferation of both SPCA-1 and PMNC cells in a intensity- and a dose-dependent manner respectively. Compared with the ultrasound (1.0 W/cm2 x 60 s) or Chlorin e6 (0.05 mg/mL-0.2 mg/mL) alone, the inhibitory effect on the cell proliferation was remarkably increased by the combination of ultrasound and chlorin e6 in SPCA-1 cells (P < 0.05), but no same effect was observed in PMNC cells (P > 0.05). Compared with the ultrasound (1.0 W/cm2 x 60 s) or chlorin e6 (0.2 mg/mL) alone, the combination treatment of ultrasound with Chlorin e6 induced more necrotic cells in SPCA-1 cells (P < 0.05).

Conclusion: There was a significant selectively inhibitory effect of sonodynamic effect with Chlorin e6 on the SPCA-1 cell growth. Chlorin e6 may be a promising sonosensitizing agent for the treatment of non-small cell lung cancer.

背景与目的: 声动力治疗(sonodynamic therapy, SDT)是通过超声波激活肿瘤细胞内聚集的声敏剂来治疗肿瘤的一种新方法。本实验用二氢卟吩e6(Chlorin e6)为声敏剂,通过超声波激活,研究其对人肺腺癌细胞SPCA-1生长的作用。

方法: 超声与Chlorin e6单独及联合处理SPCA-1细胞和正常人外周血单核细胞(normal peripheral mononuclear cell, PMNC),6 h后四甲基偶氮唑盐(3-[4, 5-dimethylthiazol-2-yl]-2, 5-diphenyl -tetrazolium bromide, MTT)显色分光光度法测细胞增殖,倒置显微镜观察细胞形态。

结果: 1.0 MHz频率超声强度1.0 W/cm2-2.0 W/cm2作用60 s呈强度依赖性抑制SPCA-1和PMNC细胞生长。Chlorin e6(0.4 mg/mL-3.2 mg/mL)浓度依赖性地抑制SPCA-1和PMNC细胞生长。与单纯超声(1.0 W/cm2×60 s×1.0 MHz)和Chlorin e6(0.05 mg/mL-0.2 mg/mL)相比,超声联合Chlorin e6对SPCA-1细胞生长抑制作用明显增强(P < 0.05),对PMNC细胞抑制作用无明显变化(P > 0.05)。细胞形态显示,与单纯超声(1.0 W/cm2×60 s×1.0 MHz)和Chlorin e6(0.2 mg/mL)相比,超声联合Chlorin e6组SPCA-1细胞死亡率明显增多(P < 0.05)。

结论: 超声联合Chlorin e6声动力可特异性抑制人肺腺癌SPCA-1细胞生长,Chlorin e6有望成为一个用于声动力治疗非小细胞肺癌的新型声敏剂。

PubMed Disclaimer

Figures

 A: structure diagram; B: absorbance spectra.
1
Chlorin e6的结构图以及紫外-可见光吸收光谱 The structure diagram and absorbance spectra of chlorin e6
2
2
超声辐照实验装置图 Ultrasonic exposure system
3
3
超声(A)及Chlorin e6(B)对SPCA-1及PMNC细胞生长的影响 Effects of ultrasound (A) and Chlorin e6 (B) on the proliferation of SPCA-1 and PMNC cells

*: <italic>P</italic> < 0.05 <italic>vs</italic> Chlorin e6; #: <italic>P</italic> < 0.05 <italic>vs</italic> 1.0 W/cm<sup>2</sup> ultrasound; E6: Chlorin e6.
4
超声联合Chlorin e6声动力对SPCA-1(A)及PMNC(B)细胞生长的影响 The sonodynamic effects, using chlorin e6 as a sonosensitizing agent activated by ultrasound, on the proliferation of SPCA-1 and PMNC cells
 A: Control; B: 1.0 W/cm<sup>2</sup> ultrasound; C: Chlorin e6 0.2 mg/mL; D: Sonodynamic effect of ultrasound with Chlorin e6.
5
倒置显微镜观察超声、Chlorin e6单独及联合声动力治疗对SPCA-1细胞存活影响(×400) Morphological analysis of SPCA-1 cell survival induced by ultrasound and chlorin e6 alone or combination treatment (×400)

Similar articles

Cited by

References

    1. Yumita N, Okuyama N, Sasaki K, et al. Sonodynamic therapy on chemically induced mammary tumor: pharmacokinetics, tissue distribution and sonodynamically induced antitumor effect of gallium-porphyrin complex ATX-70. Cancer Chemother Pharmacol. 2007;60(6):891–897. doi: 10.1007/s00280-007-0436-5. - DOI - PubMed
    1. He Y, Xing D, Yan G, et al. FCLA chemiluminescence from sonodynamic action in vitro and in vivo. Cancer Lett. 2002;182(2):141–145. doi: 10.1016/S0304-3835(02)00070-8. - DOI - PubMed
    1. Barati AH, Mokhtari-Dizaji M, Mozdarani H, et al. Treatment of murine tumors using dual-frequency ultrasound in an experimental in vivo model. Ultrasound Med Biol. 2009;35(5):756–763. doi: 10.1016/j.ultrasmedbio.2008.11.004. - DOI - PubMed
    1. Liu Q, Li X, Xiao L, et al. Sonodynamically induced antitumor effect of hematoporphyrin on Hepatoma 22. Ultrason Sonochem. 2008;15(6):943–948. doi: 10.1016/j.ultsonch.2008.04.001. - DOI - PubMed
    1. Kinoshita M, Hynynen K. Mechanism of porphyrin-induced sonodynamic effect: possible role of hyperthermia. Radiat Res. 2006;165(3):299–306. doi: 10.1667/RR3510.1. - DOI - PubMed

Publication types

MeSH terms